Editor's Note The Joint Commission announced January 4 that Northside Hospital, Atlanta, is the first in the country to receive Maternal Levels of Care Verification and the first in the state to receive a Level IV Maternal Center Designation from the Georgia Department of Public Health. Georgia is one of…

Read More

Editor's Note The Food and Drug Administration (FDA) on December 16 identified the recall by Teleflex and Arrow International, LLC, of its Arrow MAC Two-Lumen Central Venous Access Kits and Arrow Pressure Injectable Arrowg+ard Blue Plus Three-Lumen Central Venous Catheter (CVC) Kits as Class I, the most serious. The recall…

Read More

Editor's Note Workplace violence is a current obstacle nurses and healthcare workers face every day, reports December 29 Becker's Hospital Review.  In response, Healthcare communities have urged Congress to pass legislation to diminish any violent threats or attacks on hospital workers. Statistics on workplace violence against nurses, based on data…

Read More

Editor's Note The Food and Drug Administration (FDA), on December 20, identified the recall by Arrow International, LLC, subsidiary of Teleflex, Inc, of its Arrow AutoCAT 2 and AC3 intra-aortic balloon pumps (IABPs) as Class I, the most serious. IABPs are used in patients having cardiac and non-cardiac surgery, and…

Read More

Editor's Note The Joint Commission announced on December 21 that they are eliminating 168 standards (14%) and revising 14 other standards across its accreditation programs in the new year. The Joint Commission additionally announced that it will not raise accreditation fees for domestic hospitals in the coming year due the…

Read More

Editor's Note The Joint Commission announced on December 14 that it will be eliminating the term “licensed independent practitioner” from its critical access hospital and hospital programs, effective February 19, 2023. The updated terminology is consistent with that used by the Centers for Medicare and Medicaid Services Conditions of Participation…

Read More

Takeaways Many OR managers said they were overdue for a survey by The Joint Commission because of the pandemic. The Joint Commission is said to be 3,000 surveys behind. More checklists are being used by surveyors, which are available in The Joint Commission’s Perspectives and EC News newsletters. New in…

Read More

Navigating contracts with anesthesia when anesthesiology services are suffering from workforce shortages and high costs is often tricky and complex. The biggest mistake ambulatory surgery centers (ASCs) make is that they do not know what they want when entering a contract negotiation with an anesthesia provider. As a result, ASCs…

Read More

Editor's Note The Food and Drug Administration (FDA) on November 29 posted Exela Pharma Sciences’ expansion of its recall of Sodium Bicarbonate Injection, USP, 8.4%, 50 mEq/50 mL vial, 20-count carton. The product poses a safety concern because of vial breakage with flying glass when pressurized while preparing the product for…

Read More

Editor's Note The Food and Drug Administration (FDA) on December 9 identified the recall by Remel, Inc, of its Thermo Scientific Gram Negative IVD AST Sensititre Plate as Class I, the most serious. The Plates are used to test the susceptibility of Gram-negative bacterial infections to specific antibiotics. The recall…

Read More